Gunderson Dettmer represented Energy Impact Partners on the deal. Energy Impact Partners acted as the single investor in the $75 million Series C-2 financing of Coro,...
You must be a Standard 1 Year member to access this content.
Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Kala on the deal. Kala, a Colombia-based company building fintech infrastructure for lending, announced its $6 million Series Seed financing. Kala’s vertical SaaS product is...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Mercury on the deal. Mercury led the $8 million Seed financing of Brassica Technologies, an investment infrastructure for private securities and digital assets....
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Dragoneer Investment Group on the deal. Dragoneer Investment Group led the $65 million Series E financing of Teamworks, an enterprise SaaS company serving...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented ClimateAi on the deal. ClimateAi, a climate resilience platform, announced its $22 million Series B financing led by Four Rivers Group, with participation from...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised Raine Ventures on the deal. Raine Ventures announced its participation of the $15 million Series B financing of Rock The Bells, a hip...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Pipeline Therapeutics on the deal. Pipeline Therapeutics, a clinical-stage biopharmaceutical company, entered into a global license and development agreement with Janssen Pharmaceutica NV...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Enveda Biosciences on the deal. Enveda Biosciences, a drug discovery and development company, announced the additional $51 million equity financing, adding to the $68...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Belvo on the deal. Belvo, a Latin America-based open banking API platform, announced the acquisition of Skilopay, a Brazilian payment institution that allows customers...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised Eclipse on the deal. Eclipse announced the formation of its $720 million Eclipse Fund V and $510 million Eclipse Early Growth Fund II....
You must be a Standard 1 Year member to access this content.
Hunton Andrews Kurth LLP advised Mizuho Bank Ltd on the deal. Mizuho Bank Ltd. announced a $1.5 billion delayed draw term loan to Phillips 66 Company...
You must be a Standard 1 Year member to access this content.
